That’s how many of your fellow readers joined my colleague Jeff Brown for his Timed Stocks Accelerated event last night.
And judging from the feedback he got, it was a huge success.
So before we get started today, I (Chris) want to make sure it’s front and center on your radar.
As I’ve been showing you, a special group of biotech stocks has been delivering crypto-like gains in 2020.
Jeff has spent the last five years refining a strategy that maximizes the gains on offer in exactly this kind of market.
It times… often to the second… when these tiny biotech stocks explode higher.
And as he showed folks who joined him last night, two forces are now converging to accelerate the gains from these “timed stocks.” As Jeff put it…
The gains are getting bigger than ever before. They’re coming faster than ever before. And they’re happening more often than ever before.
If you’re interested in scoring wins of 1,000% or more from shares in companies working on cures for everything from cancer to COVID-19, it’s worth checking out.
You can catch the free replay here.
I first met him at a luxury ranch development on the Pacific coast of Nicaragua in February 2016. Since then, he’s had an uncanny knack for zeroing in on winning tech trends.
The first time I heard Jeff speak… he recommended a stock that went on to become the top performer in the S&P 500 that year.
I was the investment director for a family wealth project of Legacy Research cofounder Bill Bonner.
We published wealth-building research… and hosted closed-door investment meetings… for wealthy families from around the world (many of whom had held on to their wealth for generations).
Part of what we did was recommend big-picture profit trends – like I do now at the Cut. And one of the trends we were most excited about was disruptive tech.
Bill’s eldest son, Will, and I were keen to bring in someone who could show why it was so urgent that these families invest at least a portion of their fortunes in tech.
So we called in Jeff…
He gave a talk titled “High-Tech for Family Money.”
And it blew me away…
Under swirling ceiling fans in the tropical heat… to an audience of about two dozen high-net-worth individuals… Jeff explained the hidden force driving the boom – exponential growth.
He predicted it would make a suite of sci-fi technology – including self-driving cars, augmented reality, and artificial intelligence (AI) – part of our everyday lives.
And he urged folks to buy shares in specialized chipmaker Nvidia (NVDA) as a way to profit from the boom ahead.
It went on to be the top-performing stock in the S&P 500 that year. And since Jeff’s presentation, it’s currently up 1,595%.
He earned his bachelor’s degree in aeronautical and astronautical engineering – aka rocket science – from Purdue University in Indiana.
It’s one of the top schools in the field. It’s also the program 16 astronauts attended before going into space.
Then, for more than 25 years, Jeff worked as a tech industry executive in everything from semiconductors… to mobility… to digital broadcasting and video… to IT networking and security… to automotive tech… and consumer electronics.
He’s also an angel investor in early-stage tech startups. By Jeff’s estimates, 93% of the more than 145 private deals he’s invested in have made money.
And he’s a member of the Chamber of Digital Commerce. It’s an advocacy group for blockchain – the shared ledger technology behind cryptocurrencies, such as bitcoin.
And Jeff has briefed U.S. lawmakers on Capitol Hill about the merits of blockchain tech to clear up common areas of fear, uncertainty, and doubt.
In April 2019, he launched a free daily e-letter, The Bleeding Edge, to track his top tech-investing ideas.
Today, just 15 months later, he’s built a following of more than 1 million readers.
It’s easy to see why Jeff’s research and ideas about bleeding-edge tech are so popular.
Apart from the decades of industry experience he brings to the table, he travels the world to learn about the tech megatrends he tracks. Before the lockdowns, Jeff estimated he was attending almost 50 technology conferences a year. That’s almost one per week.
Last year, he attended a closed-door biotech conference at MIT… where he also studied quantum computing technology. He also advised a group of U.S. senators on a new digital dollar… and traveled to Israel on a U.S. Certified Trade Mission on blockchain and digital payments.
Jeff behind the podium at the U.S. Department of Defense
That’s all while heading our three tech-investing advisories – The Near Future Report, Exponential Tech Investor, and Early Stage Trader.
And he wasn’t a quiet student. Jeff engaged in spirited debates with the Yale bigwigs.
Jeff with Handsome Dan, the Yale mascot
In December 2018, a Yale professor lectured him on how Elon Musk’s electric carmaker, Tesla (TSLA), was on the verge of bankruptcy. The professor recommended “shorting” – or betting against – the stock.
Jeff knew Tesla had the AI clout to roll out fully autonomous (self-driving) cars. And he knew this gave the company a substantial edge over its rivals.
He stuck to his guns. And he told the professor he was dead wrong.
And since Jeff launched his first advisory with Legacy in October 2015, he’s given his paid-up subscribers the chance to close out recommendations for gains of 221% on electronic payments company Square (SQ)… 239% on project management software provider Twilio (TWLO)… 259% on electronic agreements firm DocuSign (DOCU)… 278% on chipmaker Advanced Micro Devices (AMD)… and 332% on gene-editing stock CRISPR Therapeutics (CRSP).
But right now, Jeff is most excited about another disruptive tech trend – the breakneck pace of innovation in the biotech industry.
As Jeff showed you in yesterday’s dispatch, AI and other bleeding-edge tech are accelerating the sector’s breakthroughs. What would have previously taken years is now happening in days.
This is compressing the amounts of time and money it takes to get new drugs FDA-approved. That means more profits for shareholders.
It’s down to a government mandate around getting therapies approved for public use.
When the timer hits zero, these stocks can climb hundreds of percent in a matter of days… and sometimes hours.
And here’s the best part – these are small companies that few people know about.
They are too small for pension funds and other large wealth managers to get into. And most mom-and-pop investors don’t know they exist.
Yet as Jeff revealed last night, you can buy and sell these stocks with just a few clicks in your brokerage account.
And this strategy can yield eye-popping gains. Last night, Jeff referenced timed stocks that soared 931%… 1,313%… and 1,526%.
One timed stock leapt 84,900% higher – in one day.
Jeff spent five years crafting a proprietary system to identify and trade these timed stocks. And he’s used it to identify four timed stocks with timers set to hit zero within the next two months.
It’s all in the replay of last night’s big event. Go here now to watch it.
Regards,
 |
Chris Lowe
July 16, 2020
Bray, Ireland